Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company - Stock Titan
2 days ago • Google News
Lexaria Bioscience Corp (LEXX)
US$ 2.361.72%
Price Chart
Key Statistics
Market Cap
$ 20.93M
P/E Ratio
0.00
Revenue (TTM)
$ 525.92K
Volume
210.34K
52W High
$ 4.44
52W Low
$ 1.01
Dividend Yield
0.00%
Beta
1.00
Technicals
50-Day MA
1.4036
200-Day MA
2.2583
52 Week High
4.44
52 Week Low
1.01
About LEXX
Lexaria Bioscience Corp. operates as a biotechnology company.
Employees
7
Headquarters
Kelowna, BC
CEO
Mr. Richard C. Christopher
Latest News
Lexaria (LEXX) Advances Collaborative Pharmaceutical Research | - GuruFocus
2 days ago • Google News
cheers to the chaos and the countdown! - Instagram
4 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg